Who Buys Praziquantel from India — 200 Importers Behind a $2.9M Market

The 200 buyers of Praziquantel from India can be categorized into several segments:

1. Distributors: Entities that purchase Praziquantel in bulk to supply to various healthcare providers. Examples include KHRIZ PHARMA TRADING INC (Philippines, $0.68M) and ENDURE MEDICAL, INC. (Philippines, $0.18M). These distributors typically place large, periodic orders to maintain inventory levels and meet the demands of their client base.

2. Government Procurement Agencies: Organizations responsible for acquiring medicines for public health initiatives. WHO CAMEROON (Cameroon, $0.13M) falls into this category. Such agencies often engage in tender-based purchasing, aligning orders with national health campaigns and disease control programs.

3. Non-Governmental Organizations (NGOs): Groups like MEDECINS SANS FRONTIERES LOGISTIQUE (France, $0.04M) procure Praziquantel to support their humanitarian missions. Their purchasing patterns are project-driven, with orders corresponding to the scale and duration of their health interventions.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities purchase Praziquantel to dispense directly to patients. Their orders are generally smaller and more frequent, based on patient demand and prescription rates.

5. Re-exporters: Companies that import Praziquantel for the purpose of exporting to other markets. Identifying specific re-exporters requires further analysis, but they typically order in bulk and have variable purchasing patterns depending on international demand.

6. Contract Manufacturers: Firms that procure Praziquantel as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is closely tied to production schedules and contractual obligations.

For the top five importing countries, the import regulations for Praziquantel are as follows:

The demand for Praziquantel is primarily driven by the prevalence of schistosomiasis, a parasitic disease endemic in 76 countries, with over 236 million people requiring preventive chemotherapy as of 2022. (cdn.who.int) Government healthcare programs, often supported by international organizations like the World Health Organization (WHO), play a significant role in procuring Praziquantel for mass drug administration campaigns. The inclusion of Praziquantel in the WHO Model List of Essential Medicines underscores its importance in public health initiatives.

The expansion of universal health coverage in many countries has led to increased procurement of essential medicines, including Praziquantel, through tender-based purchasing systems. This approach ensures a steady supply of the drug to meet the needs of affected populations. The presence of 200 buyers across 80 countries, as per TransData Nexus data, indicates a broad and sustained market opportunity for Praziquantel, reflecting its critical role in combating schistosomiasis globally.

The 200 buyers of Praziquantel from India can be categorized into several segments:

1. Distributors: Entities that purchase Praziquantel in bulk to supply to various healthcare providers. Examples include KHRIZ PHARMA TRADING INC (Philippines, $0.68M) and ENDURE MEDICAL, INC. (Philippines, $0.18M). These distributors typically place large, periodic orders to maintain inventory levels and meet the demands of their client base.

2. Government Procurement Agencies: Organizations responsible for acquiring medicines for public health initiatives. WHO CAMEROON (Cameroon, $0.13M) falls into this category. Such agencies often engage in tender-based purchasing, aligning orders with national health campaigns and disease control programs.

3. Non-Governmental Organizations (NGOs): Groups like MEDECINS SANS FRONTIERES LOGISTIQUE (France, $0.04M) procure Praziquantel to support their humanitarian missions. Their purchasing patterns are project-driven, with orders corresponding to the scale and duration of their health interventions.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities purchase Praziquantel to dispense directly to patients. Their orders are generally smaller and more frequent, based on patient demand and prescription rates.

5. Re-exporters: Companies that import Praziquantel for the purpose of exporting to other markets. Identifying specific re-exporters requires further analysis, but they typically order in bulk and have variable purchasing patterns depending on international demand.

6. Contract Manufacturers: Firms that procure Praziquantel as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is closely tied to production schedules and contractual obligations.

For the top five importing countries, the import regulations for Praziquantel are as follows:

The demand for Praziquantel is primarily driven by the prevalence of schistosomiasis, a parasitic disease endemic in 76 countries, with over 236 million people requiring preventive chemotherapy as of 2022. (cdn.who.int) Government healthcare programs, often supported by international organizations like the World Health Organization (WHO), play a significant role in procuring Praziquantel for mass drug administration campaigns. The inclusion of Praziquantel in the WHO Model List of Essential Medicines underscores its importance in public health initiatives.

The expansion of universal health coverage in many countries has led to increased procurement of essential medicines, including Praziquantel, through tender-based purchasing systems. This approach ensures a steady supply of the drug to meet the needs of affected populations. The presence of 200 buyers across 80 countries, as per TransData Nexus data, indicates a broad and sustained market opportunity for Praziquantel, reflecting its critical role in combating schistosomiasis globally.